De Cae, Sieglinde
Van Molle, Inge
van Schie, Loes https://orcid.org/0000-0003-2588-9750
Shoemaker, Sophie R. https://orcid.org/0000-0002-5278-2361
Deckers, Julie
Debeuf, Nincy https://orcid.org/0000-0002-4754-4772
Lameire, Sahine
Nerinckx, Wim
Roose, Kenny https://orcid.org/0000-0002-5270-4603
Fijalkowska, Daria
Devos, Simon
De Smet, Anne-Sophie
Marchan, Jackeline Cecilia Zavala
Venneman, Toon
Sedeyn, Koen https://orcid.org/0000-0002-1303-1629
Mujanovic, Lejla
Ballegeer, Marlies
Vanheerswynghels, Manon
De Wolf, Caroline
Demol, Hans
Zuallaert, Jasper
Vanhaverbeke, Pieter
Ghassabeh, Gholamreza Hassanzadeh
Lonigro, Chiara https://orcid.org/0000-0002-9523-7929
Bockstal, Viki
Rinaldi, Manuela
Abdelnabi, Rana https://orcid.org/0000-0001-9771-7312
Neyts, Johan https://orcid.org/0000-0002-0033-7514
Marqusee, Susan https://orcid.org/0000-0001-7648-2163
Lambrecht, Bart N.
Callewaert, Nico https://orcid.org/0000-0003-2069-6917
Remaut, Han https://orcid.org/0000-0002-9775-4102
Saelens, Xavier https://orcid.org/0000-0002-3861-6965
Schepens, Bert https://orcid.org/0000-0002-2028-1984
Article History
Received: 16 August 2024
Accepted: 19 May 2025
First Online: 30 May 2025
Competing interests
: S.D.C., B.S., X.S., L.v.S., W.N., K.R., N.C., G.H.G., H.R., I.V.M., V.B., and R.M. are named as inventors on patent application WO2023/222825 A1 “Sarbecovirus Spike S2 Subunit Binders”. N.C. and X.S. are scientific founders of ExeVir Bio BV and are in receipt of ExeVir Bio BV share options. T.V. and V.B. are and M.R. and C.L. were employed by ExeVir Bio BV and are in receipt of ExeVir Bio BV share options. All other authors declare that they have no competing interests.